Optina Diagnostics

Optina Diagnostics is revolutionizing medical diagnostics with our Retinal Deep Phenotyping platform that brings clarity and accessibility to early-stage diagnosis of diseases of the eye, and so much more. Optina aims to improve the lives of older adults by making diagnosis and precision medicine a reality. We are addressing major challenges faced by healthcare systems that support aging populations. The Optina-4C hyperspectral camera for imaging the retina (back of the eye) is FDA-cleared and licensed by Health Canada. It brings a new dimension to medical imaging - the power of the spectral (color) dimension - and reveals unprecedented information about cellular and molecular changes. Optina's Retinal Deep Phenotyping platform combines data-rich images from the Optina-4C camera with Artificial intelligence-driven algorithms to deliver automated, accessible, and equitable diagnostic information about eye diseases like Age-related Macular Degeneration, as well as systemic diseases like Alzheimer's and cardiac stenosis. Optina has been granted Breakthrough Device Designation by the FDA for our Alzheimer's test which enables a dramatic improvement in the differential diagnosis of dementia.